Celldex shares slip 15% as safety concerns cloud skin drug trial win
N
Nimisham EditorialSenior Editorial Lead
Nimisham
Source Attribution:
Updated:
Celldex shares slip 15% as safety concerns cloud skin drug trial win
Nimisham EditorialSenior Editorial Lead
Nimisham
Source Attribution: